EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mitochondrial dysfunction and cisplatin sensitivity in gastric cancer: GDF15 as a master player

Maria Cavinato iD

The FEBS Journal · 2024

DOI: 10.1111/febs.17087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Maria Cavinato. Beteiligte Einrichtung: Institute for Biochemical Aging Research, University of Innsbruck, Austria. Hauptthemen laut MEDLINE: Stomach Neoplasms, Mitochondrial Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer, a major global health concern, poses challenges in effective treatment, notably due to chemoresistance. This study investigates the role of growth/differentiation factor‐15 (GDF‐15) in mitochondrial dysfunction and its impact on cisplatin sensitivity in gastric cancer cells. In this issue of The FEBS Journal , Wang et al . demonstrate that GDF15 upregulation is associated with cisplatin insensitivity, mediated by the ATF4‐CHOP pathway and reactive oxygen species‐activated general control nonderepressible 2 [Wang S‐F et al . (2023) FEBS J , https://doi.org/10.1111/febs.16992 ]. Connecting these insights, we explore the broader implications of GDF15 expression in the aging‐cancer axis, particularly its involvement in cellular senescence and the senescence‐associated secretory phenotype (SASP). This study suggests that GDF15 released by senescent cells could contribute to tumor progression, indicating potential avenues for therapeutic intervention by targeting senescent cells and their SASP. While the study provides valuable insights into mitigating cisplatin resistance, further research is crucial to fully understand the role of GDF15 in the tumor microenvironment and its potential feedback loops promoting tumorigenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsMitochondrial DiseasesHumansCisplatinGrowth Differentiation Factor 15Cellular SenescenceTumor Microenvironment

Stichwörter der Autor:innen

GDF15cancercisplatin resistancesenescence

Substanzen

CisplatinGrowth Differentiation Factor 15GDF15 protein, human

Autor:innen und Institutionen

  • Institute for Biochemical Aging Research, University of Innsbruck, Austria.
  • Center for Molecular Biosciences Innsbruck (CMBI), Austria.

ORCID-Profile: Maria Cavinato

Zitieren

APA

Cavinato, M. (2024). Mitochondrial dysfunction and cisplatin sensitivity in gastric cancer: GDF15 as a master player. The FEBS Journal. https://doi.org/10.1111/febs.17087

Vancouver

Cavinato M. Mitochondrial dysfunction and cisplatin sensitivity in gastric cancer: GDF15 as a master player. The FEBS Journal. 2024. doi:10.1111/febs.17087

BibTeX
@article{Cavinato2024,
  author = {Cavinato, Maria},
  title = {Mitochondrial dysfunction and cisplatin sensitivity in gastric cancer: GDF15 as a master player},
  journal = {The FEBS Journal},
  year = {2024},
  doi = {10.1111/febs.17087}
}
Kostenlos starten →